Downregulation of TAB182 Promotes Cancer Stem-Like Cell Properties and Therapeutic Resistance in Triple-Negative Breast Cancer Cells

The authors revealed a novel function of TAB182 as a potential negative regulator of cancer stem-like properties and drug sensitivity in triple-negative breast cancer cells.